Cytokinetics, Inc. (CYTK)
77.19
+0.90
(+1.18%)
USD |
NASDAQ |
May 27, 16:00
76.65
-0.54
(-0.70%)
After-Hours: 16:33
Cytokinetics Free Cash Flow : -548.92M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BridgeBio Pharma, Inc. | -452.02M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| Ionis Pharmaceuticals, Inc. | -977.73M |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -145.46M |
| Cash from Investing (Quarterly) | 145.49M |
| Cash from Financing (Quarterly) | 7.77M |
| Free Cash Flow Per Share (Quarterly) | -1.228 |
| Free Cash Flow to Equity (Quarterly) | -155.87M |
| Free Cash Flow to Firm (Quarterly) | -118.05M |
| Free Cash Flow Yield | -5.86% |